Getting fat payouts for zero or even negative performance is no longer the realm of Wall Street banks. In Minnesota, one public company paid out $1.35 million to switch CEOs three times over a short period of time, all the while showing losses, reports the Star Tribune. Angeion (NASDAQ:ANGN), a Vadnais Heights, Minnesota-based company that makes cardio-respiratory […]
Interim CEO Gregg Lehman at Angeion (NASDAQ:ANGN) has been retained as chief executive of the the St. Paul, Minnesota, company that designs, manufactures and distributes cardiorespiratory diagnostic systems. Lehman joined the company in May following the sudden (some believe forced) departure of its previous CEO Phil Smith after just six months on the job. The previous […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A day after shaking up its senior management, Angeion Corp. reported flat revenue in its second fiscal quarter and a narrowed loss. The company reversed its decision to hold its routine conference call with analysts — something that was reiterated in a May 16 news release — implying that CEO Phil Smith’s departure after less […]
Update: 1:45 p.m. St. Paul, Minnesota-based public company Angeion Corp. made a surprising announcement this morning. CEO Phillip Smith is leaving the company after less than six months on the job. In a tersely worded statement, the company said Smith resigned after he and Angeion’s board reached a “mutual decision.” This is all the more […]
St. Paul-based Angeion Corp. named Rob Wolf its chief financial officer and Mark Gryzwa its vice president of engineering effective Monday. Wolf and Gryzwa will report to Phil Smith, the CEO of Angeion, the St. Paul, Minnesota company that makes noninvasive cardiorespiratory diagnostic systems. Wolf replaces Larry Degen, Angeion’s interim CFO, who will continue with […]
A stronger market for its diagnostic systems and an emphasis on sales and marketing sent Angeion Corp.'s (NASDAQ:ANGN) fourth-quarter earnings into the black. It's been a rough year (actually, last several years) for the company, having survived the threat of a proxy battle and the termination of its CFO, but credit Angeion for ending on a strong note.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Troubled diagnostic systems maker Angeion Corp. (NASDAQ: ANGN) has restructured its board of directors to quell a proxy fight with activist shareholder BlueLine Partners LLC. Danville, California-based BlueLine Partners, which owns 7.2 percent of Angeion's outstanding shares, was gathering shareholder signatures in an effort to remove Angeion's directors --whose "advice and consent" style of corporate governance is failing to turn around the company -- and replace them with a new board nominated by shareholders.
A shareholder of struggling Angeion Corp. (Nasdaq: ANGN) blasted the company for poor performance and seeks to rally other shareholders in an effort to oust the Minnesota device company’s board. Danville, California-based BlueLine Partners, which owns 7.2 percent of Angeion’s outstanding shares, is attempting to gather signatures from other shareholders in an effort to remove […]
Angeion Corp. (NASDAQ: ANGN), a medical device company based in St. Paul, Minn., has fired its chief financial officer, according to documents filed with the Securities and Exchange Commission. William J. Kullback, a senior vice president and Angeion’s No. 2 corporate officer behind CEO Rodney Young, will be replaced on an interim basis by corporate […]